Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Erin Borger and Paul Blom Join NPF's Board of Directors

MIAMI,FL — The National Parkinson Foundation (NPF) announced the election of two new members to its Board of Directors: Erin R. Borger and Paul R. Blom. 

"We are pleased to add individuals with diverse backgrounds and geographies to NPF’s Board—our goal is to have NPF be truly representative of the Parkinson’s community," stated John W. Kozyak, Esq., NPF Chairman of the Board. "Erin and Paul’s combined experience will help move the mission of NPF forward to make life better for people with Parkinson’s and their families.”

Erin R. Borger was elected to the board in December 2014. Mr. Borger is in charge of Wealth Management in Northern California for UBS Financial Services. He serves as the Complex Director, overseeing $15 billion in assets in eight offices. He has served with UBS Financial since 2008, including his previous roles as Director, Branch Manager based in Florida and Management Training Advisor based in New York and New Jersey. Mr. Borger began his career with Morgan Stanley in 2003 as a Financial Advisor. Mr. Borger has long held an interest in neurological conditions and has supported various philanthropies personally and through his family foundation. He serves on the Board of Trustees: Visiting Committee and Neurology Committee for the University of Miami, Miller School of Medicine. He is also currently on the Cystic Fibrosis Foundation Advisory Board and F.I.N. Sea Foundation's Board of Directors. 

Paul R. Blom was elected to the board in November 2014, as an ex officio member. Mr. Blom recently served as the president of the NPF Minnesota Board of Directors for the past ten years and is the current Chair of NPF’s Chapter Advisory Council, working to strengthen the NPF Chapter network. A strong advocate for the Parkinson’s community, he has served as a member of the Community Advisory Board for Struthers Parkinson’s Center, an NPF Center of Excellence. Mr. Blom and his husband, Bob White, are the owners of the Right at Home franchise in Bloomington, MN, and were instrumental in helping to secure the Right at Home franchise’s national sponsorship of Moving Day®, NPF’s signature fundraising walk.  Additionally, Mr. Blom serves as Vice-Chair of Training to Serve, a Minnesota non-profit that provides training for senior service providers regarding the unique needs and barriers of the aging LGBT community.  He also serves on the boards of Avenues for Homeless Youth and the Twin Cities Gay Men’s Chorus, and he is Treasurer of the Minneapolis Area Senior Workers Association.

Alan M. Slewett, who has been on the NPF board since 2001, became a member of the NPF Emeritus board as of January 2015. Mr. Slewett is the former President of Valentine Liquors, Inc., a Miami area chain of retail liquor and grocery stores.  He is the son of Nathan Slewett, the longtime, former President and Chairman Emeritus of the National Parkinson Foundation. 

“Alan Slewett has been a dedicated Board member and valued supporter in his own right,” stated John W. Kozyak, Esq. “We are honored to have his continued involvement as an Emeritus member of the Board.”

View a complete list of the NPF Board of Directors.

About Parkinson's Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Tuesday, January 13, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.